Vimarsana
Biggest News Aggregation in the World

Page 44 - Immune News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immune. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immune Today - Breaking & Trending Today

Finding the good in autoantibodies could REAP broad benefits - Vimarsana News

Finding the good in autoantibodies could REAP broad benefits

Autoantibodies call to mind disease – autoimmune disease, to be exact. But the physiological roles of autoantibodies are, at the very least, more complex than this view accounts for. “The autoantibody reactome is extraordinary,” Aaron Ring told BioWorld. “Nearly everyone has autoantibodies, whether they know it or not.”

AAAS 2024: Chemo brain, other conditions provide lens for long COVID - Vimarsana News

AAAS 2024: Chemo brain, other conditions provide lens for long COVID

The biological processes giving rise to the central nervous system symptoms of long COVID remain a mystery. But multiple studies suggest they do not appear to be a result of a direct viral infection of brain tissue. The latest such research, which appeared online in Nature Neuroscience on Feb. 16, 2024, demonstrated that local immune response in brain tissues persisted long after SARS-CoV-2 virus had disappeared.

COVID-19 infection does not damage immune system memory, Finnish study confirms - Vimarsana News

COVID-19 infection does not damage immune system memory, Finnish study confirms

Finnish researchers have provided reassuring news that COVID-19 infection does not harm the long-lasting immunological memory brought about by vaccines. This discovery addresses widespread concerns that coronavirus might permanently weaken the immune defense system, similar to the way measles virus can impair immunological memory. Published in peer-reviewed scientific journals, Pathogens and Immunity and Virus Research,

Multivalent mRNA vaccine prevents mpox disease - Vimarsana News

Multivalent mRNA vaccine prevents mpox disease

A vaccine based on messenger RNA (mRNA) technology against four surface proteins of the envelope and the inner membrane of the mpox virus (MPXV) demonstrated its efficacy in two animal models. Biontech SE scientists designed and tested two different combinations of antigens in mice and macaques for the two infective forms of the virus. One of them showed better results for its evaluation in clinical trials preventing the disease.

Big issues with Paddy Gower Has Issues as Three hiring freeze bites popular show - Vimarsana News

Big issues with Paddy Gower Has Issues as Three hiring freeze bites popular show

It’s one of Three’s biggest shows with one of its biggest names - but it’s not immune to a hiring freeze that has already pushed the release of other shows...